Ivermectin: facts and science are in its favour – Dr Rapiti

Loading player...
In August 2021, BizNews conducted a panel discussion with Professor Colleen Aldous, Dr Nathi Mdladla and Dr Pinky Ngcakani – all of whom are strongly in favour of ivermectin. The discussion was published on BizNews TV on YouTube and for a year, it managed to evade the YouTube censorship police. Last week, Results of a Prospective Observational Study of a Strictly Controlled Population of 88,012 Subjects showed that Regular Use of Ivermectin as Prophylaxis for COVID-19 led to a 92% Reduction in COVID-19 Mortality Rate in a Dose-Response Manner. First thing this morning, BizNews received notification of a strike on our BizNews TV YouTube channel on account of the ivermectin panel discussion, which was taken down. The timing appears too odd for coincidence. What may be more realistic is that the World Health Organisation, which is in close ‘cahoots’ with YouTube, is doing a sweep of all pro-ivermectin content. This is the original ivermectin panel discussion podcast. Learn more about your ad choices. Visit megaphone.fm/adchoices
5 Sep 2022 11AM English South Africa Investing · Business News

Other recent episodes

The BizNews Edge: African Bank's Billion-Rand Acquisition Trap

African Bank swung to a loss of nearly a billion rand after a four-year spree of buying and bolting together three banks to build a full-service lender, and the bad debt charge is still climbing. The contrast is brutal: a focused platinum-and-chrome miner, Tharisa, is printing cash with profit up…
25 Jun 7AM 9 min

The BizNews Edge: Nedbank, Grindrod and the coal stock no one was watching

Nedbank confirmed its guidance this morning, and its East Africa deal is weeks from closing - a transformation most investors are still underpricing. Grindrod's Port of Maputo posted extraordinary volumes, but the share may already be priced for perfection. A small coal miner no one follows just disclosed an 1,800%…
24 Jun 8AM 26 min